title: Diabetes in HIV-infected persons in Cameroon?
abstract: In the past, the increased prevalence of diabetes in HIV infection has been attributed to antiretroviral drugs. In this study, Cameroonians with HIV infection were shown in a paper in this issue of the Journal to be more likely to have diabetes if they were not on therapy. Future research should examine if the diabetes is related to the host response to infection or to socioeconomic factors that might both contribute to not being on anti-retroviral therapy and predispose to diabetes. Copyright © 2016 John Wiley & Sons, Ltd.
authors.affiliation: San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.|Department of Medicine, Division of Endocrinology and Metabolism, University of California, San Francisco, CA, USA.|Northern California Institute for Research and Education, San Francisco, CA, USA.
authors.forename: Carl
authors.initials: C
authors.lastname: Grunfeld
authors.affiliation: School of Public Health, Department of Epidemiology and Preventive Medicine, Tel Aviv University, Tel Aviv, Israel.|Patient Oriented Research, The Feinstein Institute for Medical Research, Manhasset, NY, USA.
authors.forename: Rachel
authors.initials: R
authors.lastname: Dankner
mesh_terms: D002163:Cameroon / Q000453:epidemiology; D003920:Diabetes Mellitus / Q000453:epidemiology* / Q000209:etiology; D015658:HIV Infections / Q000150:complications / Q000821:virology*; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D015995:Prevalence; D011379:Prognosis
keywords: HIV-infected patients; diabetes; protease inhibitors